Skip to main content
Erschienen in: Pathology & Oncology Research 2/2012

01.04.2012 | Research

Association of Expression of Kruppel-Like Factor 4 and Kruppel-Like Factor 5 with the Clinical Manifestations of Breast Cancer

verfasst von: Chih-Jung Chen, Sey-En Lin, Yueh-Min Lin, Shu-Hui Lin, Dar-Ren Chen, Chi-Long Chen

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Kruppel-like factors (KLFs) are import modulators of cell proliferation, differentiation, and transformation and have recently been considered possible prognostic factors in breast cancer. In this study, we investigated the correlation between KLF4 and KLF5 expression and the clinical manifestations of breast cancer by immunohistochemical analysis. We observed increased KLF4 and KLF5 expression in tumor cells (invasive and in situ carcinomas), consistent KLF4 and KLF5 expression in in situ and invasive carcinomas, significant associations between KLF4 expression and tumor grade (p = 0.033), size (p = 0.035) and stage (p = 0.006), and an association between KLF5 expression and tumor grade (p = 0.033). Interestingly, we observed a relationship between increasing age and KLF4 expression (p = 0.007), with a tendency towards greater expression in tumor cells in patients over 50 years old. Moreover, KLF5 nuclear localization was restricted to non-tumor breast ducts and lobules; however, loss of nuclear expression of KLF5 in in situ and invasive carcinomas was observed. Although the mechanism of the loss of KLF5 nuclear expression is not clear, this phenomenon may imply a possible tumor-suppressor-like role for KLF5 in breast cancer tumorigenesis. The expression of KLF4 and KLF5 in breast cancer patients in Taiwan is similar to that in Western countries, except for the uncertainty surrounding its prognostic significance. Further clarification of the underlying mechanisms of KLF4 and KLF5 expression and their correlations with breast cancer outcomes is necessary.
Literatur
1.
Zurück zum Zitat Cheng SH, Tsou MH, Liu MC et al (2000) Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 63:213–223PubMedCrossRef Cheng SH, Tsou MH, Liu MC et al (2000) Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 63:213–223PubMedCrossRef
2.
Zurück zum Zitat Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143–160PubMedCrossRef Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143–160PubMedCrossRef
3.
Zurück zum Zitat Dang DT, Pevsner J, Yang VW (2000) The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol 32:1103–1121PubMedCrossRef Dang DT, Pevsner J, Yang VW (2000) The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol 32:1103–1121PubMedCrossRef
4.
Zurück zum Zitat Turner J, Crossley M (1999) Mammalian Krüppel-like transcription factors: more than just a pretty finger. Trends Biochem Sci 24:236–240PubMedCrossRef Turner J, Crossley M (1999) Mammalian Krüppel-like transcription factors: more than just a pretty finger. Trends Biochem Sci 24:236–240PubMedCrossRef
5.
Zurück zum Zitat Clarke ND, Berg JM (1998) Zinc fingers in Caenorhabditis elegans: finding families and probing pathways. Science 282:2018–2022PubMedCrossRef Clarke ND, Berg JM (1998) Zinc fingers in Caenorhabditis elegans: finding families and probing pathways. Science 282:2018–2022PubMedCrossRef
6.
Zurück zum Zitat Pandya AY, Talley LI, Frost AR et al (2004) Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 10:2709–2719PubMedCrossRef Pandya AY, Talley LI, Frost AR et al (2004) Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 10:2709–2719PubMedCrossRef
7.
Zurück zum Zitat Tong D, Czerwenka K, Heinze G et al (2006) Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res 12:2442–2448PubMedCrossRef Tong D, Czerwenka K, Heinze G et al (2006) Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res 12:2442–2448PubMedCrossRef
8.
Zurück zum Zitat Guo H, Lin Y, Zhang H et al (2007) Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol Biol 8:110PubMedCrossRef Guo H, Lin Y, Zhang H et al (2007) Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol Biol 8:110PubMedCrossRef
9.
Zurück zum Zitat Wang X, Zheng M, Liu G et al (2007) Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 67:7184–7193PubMedCrossRef Wang X, Zheng M, Liu G et al (2007) Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 67:7184–7193PubMedCrossRef
10.
Zurück zum Zitat Ghaleb AM, Nandan MO, Chanchevalap S et al (2005) Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15:92–96PubMedCrossRef Ghaleb AM, Nandan MO, Chanchevalap S et al (2005) Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15:92–96PubMedCrossRef
11.
Zurück zum Zitat Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumor suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7:1074–1082PubMedCrossRef Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumor suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7:1074–1082PubMedCrossRef
12.
Zurück zum Zitat Rowland BD, Peeper DS (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6:11–23PubMedCrossRef Rowland BD, Peeper DS (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6:11–23PubMedCrossRef
13.
Zurück zum Zitat Miller KA, Eklund EA, Peddinghaus ML et al (2001) Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells. J Biol Chem 276:42863–42868PubMedCrossRef Miller KA, Eklund EA, Peddinghaus ML et al (2001) Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells. J Biol Chem 276:42863–42868PubMedCrossRef
14.
Zurück zum Zitat Foster KW, Ren S, Louro ID et al (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 10:423–434PubMed Foster KW, Ren S, Louro ID et al (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 10:423–434PubMed
15.
Zurück zum Zitat Foster KW, Frost AR, McKie-Bell P et al (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60:6488–6495PubMed Foster KW, Frost AR, McKie-Bell P et al (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60:6488–6495PubMed
16.
Zurück zum Zitat Chen C, Bhalala HV, Qiao H et al (2002) A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21:6567–6572PubMedCrossRef Chen C, Bhalala HV, Qiao H et al (2002) A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21:6567–6572PubMedCrossRef
17.
Zurück zum Zitat Chen C, Zhou Y, Zhou Z et al (2004) Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene 330:133–142PubMedCrossRef Chen C, Zhou Y, Zhou Z et al (2004) Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene 330:133–142PubMedCrossRef
19.
Zurück zum Zitat Rosen PP (2009) Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate. In: Rosen PP (ed) Rosen’s breast pathology. Lippincott Williams & Wilkins, Philadelphia, pp 358–404 Rosen PP (2009) Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate. In: Rosen PP (ed) Rosen’s breast pathology. Lippincott Williams & Wilkins, Philadelphia, pp 358–404
20.
Zurück zum Zitat Chen C, Sun X, Guo P et al (2005) Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 280:41553–41561PubMedCrossRef Chen C, Sun X, Guo P et al (2005) Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 280:41553–41561PubMedCrossRef
21.
Zurück zum Zitat Graham JD, Yager ML, Hill HD et al (2005) Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 19:2713–2735PubMedCrossRef Graham JD, Yager ML, Hill HD et al (2005) Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 19:2713–2735PubMedCrossRef
22.
Zurück zum Zitat Beckers J, Herrmann F, Rieger S et al (2005) Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int J Cancer 114:590–597PubMedCrossRef Beckers J, Herrmann F, Rieger S et al (2005) Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int J Cancer 114:590–597PubMedCrossRef
Metadaten
Titel
Association of Expression of Kruppel-Like Factor 4 and Kruppel-Like Factor 5 with the Clinical Manifestations of Breast Cancer
verfasst von
Chih-Jung Chen
Sey-En Lin
Yueh-Min Lin
Shu-Hui Lin
Dar-Ren Chen
Chi-Long Chen
Publikationsdatum
01.04.2012
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2012
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-011-9422-7

Weitere Artikel der Ausgabe 2/2012

Pathology & Oncology Research 2/2012 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.